SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15821208
Source:
http://linkedlifedata.com/resource/pubmed/id/15821208
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019863
,
umls-concept:C0033167
,
umls-concept:C0392751
,
umls-concept:C0580352
,
umls-concept:C1609538
,
umls-concept:C1705413
pubmed:issue
4
pubmed:dateCreated
2005-4-11
pubmed:abstractText
Recently, a short-course treatment using 60 daily doses of rifampin and pyrazinamide was recommended for latent tuberculosis (TB) infection (LTBI).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0231335
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazinamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0012-3692
pubmed:author
pubmed-author:2RZ Study Group
,
pubmed-author:BockNaomi NNN
,
pubmed-author:GrabauJohn CJC
,
pubmed-author:JasmerRobert MRM
,
pubmed-author:LobatoMark NMN
,
pubmed-author:RevesRandall RRR
,
pubmed-author:ShangNongN
pubmed:issnType
Print
pubmed:volume
127
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1296-303
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15821208-Adolescent
,
pubmed-meshheading:15821208-Adult
,
pubmed-meshheading:15821208-Aged
,
pubmed-meshheading:15821208-Antitubercular Agents
,
pubmed-meshheading:15821208-Cohort Studies
,
pubmed-meshheading:15821208-Drug-Induced Liver Injury
,
pubmed-meshheading:15821208-Female
,
pubmed-meshheading:15821208-Homeless Persons
,
pubmed-meshheading:15821208-Humans
,
pubmed-meshheading:15821208-Male
,
pubmed-meshheading:15821208-Middle Aged
,
pubmed-meshheading:15821208-Patient Compliance
,
pubmed-meshheading:15821208-Prisoners
,
pubmed-meshheading:15821208-Pyrazinamide
,
pubmed-meshheading:15821208-Rifampin
,
pubmed-meshheading:15821208-Tuberculosis, Pulmonary
pubmed:year
2005
pubmed:articleTitle
Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons.
pubmed:affiliation
CDC, 1600 Clifton Rd, Mailstop E-10, Atlanta, GA 30333, USA. mnl0@cdc.gov
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.
,
Multicenter Study